Dextera Surgical Inc. (NASDAQ:DXTR) – Research analysts at Wedbush increased their FY2017 earnings per share estimates for shares of Dextera Surgical in a report issued on Wednesday. Wedbush analyst Levy. T now forecasts that the medical instruments supplier will earn ($0.98) per share for the year, up from their prior forecast of ($1.61). Wedbush currently has a “Outperform” rating and a $0.70 target price on the stock. Wedbush also issued estimates for Dextera Surgical’s Q4 2017 earnings at ($0.10) EPS, FY2018 earnings at ($0.19) EPS and FY2019 earnings at ($0.15) EPS.
Dextera Surgical (NASDAQ:DXTR) last announced its quarterly earnings results on Thursday, May 4th. The medical instruments supplier reported ($0.50) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.48) by $0.02. The business had revenue of $1.11 million for the quarter, compared to analysts’ expectations of $1.10 million.
Separately, Zacks Investment Research upgraded Dextera Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 30th.
Shares of Dextera Surgical (DXTR) traded up 2.857% during midday trading on Friday, reaching $0.288. 402,764 shares of the company’s stock traded hands. Dextera Surgical has a 52-week low of $0.17 and a 52-week high of $2.94. The stock’s market cap is $2.57 million. The stock has a 50 day moving average of $0.23 and a 200-day moving average of $0.92.
Dextera Surgical Company Profile
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with our FREE daily email newsletter.